University of Miami

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).

721 total trials 145 currently recruiting 430 completed early-phase tilt top decile by trial count

University of Miami: 721 sponsored US clinical trials, 145 recruiting.

University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.

Top-decile sponsor footprint

University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 48/100

430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

721 total, page 5 of 15

NOT YET RECRUITING Phase 4

Prophylactic Antibiotics for Outpatient Urethral Bulking

NCT07501065

NOT YET RECRUITING Phase 4

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

NCT07278362

NOT YET RECRUITING NA

Hypoxia and Heart Rate Variability

NCT05606406

NOT YET RECRUITING Phase 4

Dose Dependent Steroid Injections

NCT07494136

NOT YET RECRUITING NA

Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer

NCT07518888

NOT YET RECRUITING NA

Facial Papules in Frontal Fibrosing Alopecia (FFA)

NCT07340671

COMPLETED NA

AIR Support: Artificially Intelligent Robot (AIR) Support for Pediatric Asthma Education

NCT07387718

COMPLETED NA

Mindfulness Training for First Responders

NCT06582927

TERMINATED NA

FITLIGHT Reliability and Acute Training Effects

NCT06748417

COMPLETED NA

Top Set and Parkinson's Disease

NCT06801704

COMPLETED NA

How Does the Type of Waveform Affect Tolerability With Transcutaneous Auricular Vagus Nerve Stimulation?

NCT06614933

COMPLETED NA

Effect of Music and Mindfulness Meditation

NCT06704841

COMPLETED NA

The Effect of Music Listening on Nursing Students

NCT06647420

COMPLETED NA

Cluster Resistance Training and Older Adults

NCT06588842

COMPLETED NA

Online Exposure Therapy for Obsessive-Compulsive Disorder (OCD) Study

NCT06470893

COMPLETED NA

Interval Training and Parkinson's Disease

NCT06606743

COMPLETED NA

Jump Start on the Go: Improving Resiliency and the Social-Emotional Development of At-Risk Preschool Children

NCT06374550

TERMINATED

Study of OmniGraft in Simultaneous Pancreas Kidney Recipients

NCT06463873

COMPLETED NA

The Development and Evaluation of a Single Session Intervention for Parent Distress Tolerance

NCT05955898

COMPLETED NA

Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1

NCT06381102

COMPLETED Phase 4

Phenylephrine Versus Eyelid Taping for Muller's Muscle-Conjunctival Resection (MMCR) Evaluation

NCT05890027

COMPLETED NA

Virtual Reality (VR) Regulators

NCT06184529

COMPLETED NA

The Short-term Impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on Respiratory Function in Patients With Lung Cancer

NCT06172959

COMPLETED NA

The Effect of Music-Based Mindfulness to Cope with Acculturative-Related Stress

NCT06166732

TERMINATED Phase 1

Combining Shockwave Therapy and Platelet Rich Plasma to Treat Erectile Dysfunction in Diabetic Men (COCKTAIL-DM)

NCT05525572

COMPLETED NA

Mindfulness Training in the Medical Health Care System

NCT06003699

COMPLETED NA

Aromatherapy Effect on Anxiety Prior to Ultrasound Guided Musculoskeletal Procedures

NCT05660486

TERMINATED Phase 4

C-Cog in Early Course Schizophrenia Study

NCT05662306

COMPLETED NA

Yoga Training and Retinal Vasculature With Parkinson's Disease

NCT06194227

COMPLETED NA

Addressing Disparities in Neuromodulation for Rehabilitation: A Mixed Methods Approach to Optimize Access for Underrepresented Racial Minorities

NCT05896202

COMPLETED NA

Balance Targeted Exercises for Individuals With MS

NCT06159361

COMPLETED NA

Integrated Behavioral Healthcare for Youth With Type 1 Diabetes

NCT05915975

COMPLETED NA

Within My Reach (WMR) Adaptation

NCT06056661

COMPLETED Phase 4

Pre vs Post Block in Total Knee Arthroplasty (TKA)

NCT05974501

COMPLETED NA

Yoga Training and Retinal Vasculature

NCT06099405

COMPLETED NA

Nutrition Education Program in Spinal Cord Injury (SCI)

NCT05953597

COMPLETED NA

Virtual Reality for Youth Phobias

NCT05839431

COMPLETED NA

The Impact of Respiratory Muscle Training and Patient Education on Chronic Constipation Outcomes

NCT05823259

TERMINATED Phase 4

The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days

NCT05545735

COMPLETED NA

Mindfulness Training Hidradenitis Suppurativa (HS)

NCT05642039

COMPLETED Phase 2

Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)

NCT05776862

COMPLETED NA

Sleep, Diet, Exercise and Older Persons

NCT05735353

COMPLETED NA

Telemonitored Exercise to Attenuate Metabolic Dysregulation in Spinal Cord Injury

NCT05597176

COMPLETED NA

Web-Based Cognitive Behavioral Stress Management for Latino Sexual Minority Men Living With HIV and Cancer

NCT03993054

COMPLETED NA

Feeding Regulation in SCI

NCT05406739

TERMINATED Phase 4

Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure

NCT06080438

TERMINATED NA

Virtual Reality Technology for Vasectomy Pain Modulation

NCT05591274

TERMINATED NA

Mindfulness Training for Senior Leaders

NCT04576832

COMPLETED NA

Infant-Directed Singing for At-Risk Mothers and Infants

NCT05483153

COMPLETED NA

Pain and Hysteroscopy

NCT05316506

← Previous Page 5 of 15 Next →

Phase Distribution

PhaseTrial count
Phase 1 48
Phase 2 86
Phase 3 18
Phase 4 61

What is open in the University of Miami pipeline

145 recruiting of 721 indexed (20% open); 430 completed (60%).

Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).

Top condition: Prostate Cancer (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Miami: open-pipeline peers nationwide

Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 5%10%15%20%25% Total trials Recruiting share University of MiamiSanofiThe University of Texas Health Science Center, HoustonIcahn School of Medicine at Mount SinaiWeill Medical College of Cornell UniversityUniversity of California, IrvineEndeavor HealthAcera SurgicalAlign Technology
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 721 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

What to do with this University of Miami page

721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.

  • 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Miami pipeline card: 721 registered trials from official public datasets.Report a data error.